8-[1-[(1-methylpyrrolidin-3-yl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dione;trifluoromethylbenzene
C27H34F3N7O2 — CID 143868257
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[1-[(1-methylpyrrolidin-3-yl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dione;trifluoromethylbenzene
8-[1-[(1-methylpyrrolidin-3-yl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dione;trifluoromethylbenzene (PubChem CID 143868257) has the molecular formula C27H34F3N7O2 and a molecular weight of 545.61 g/mol. Its IUPAC name is 8-[1-[(1-methylpyrrolidin-3-yl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dione;trifluoromethylbenzene.
Molecular Properties
| Compound Name | 8-[1-[(1-methylpyrrolidin-3-yl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dione;trifluoromethylbenzene |
|---|---|
| PubChem CID | 143868257 |
| Molecular Formula | C27H34F3N7O2 |
| Molecular Weight | 545.61 g/mol |
| Exact Mass | 545.27 |
| IUPAC Name | 8-[1-[(1-methylpyrrolidin-3-yl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dione;trifluoromethylbenzene |
| SMILES | CCCn1c(=O)c2[nH]c(-c3cnn(CC4CCN(C)C4)c3)nc2n(CCC)c1=O.FC(F)(F)c1ccccc1 |
| InChI | InChI=1S/C20H29N7O2.C7H5F3/c1-4-7-26-18-16(19(28)27(8-5-2)20(26)29)22-17(23-18)15-10-21-25(13-15)12-14-6-9-24(3)11-14;8-7(9,10)6-4-2-1-3-5-6/h10,13-14H,4-9,11-12H2,1-3H3,(H,22,23);1-5H |
| InChIKey | NLNAQIRYQJLZIN-UHFFFAOYSA-N |
| XLogP | 4.23 |
| TPSA | 93.74 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 545.61 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143868257 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.